Evidence-based pharmacogenetic guidelines in the Netherlands
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: VAN RHENEN, Mandy (Royal Dutch Pharmacists Association (KNMP), Center for Information on Medicines, The Hague, Netherlands)
- Co-author(s): Nijenhuis, Marga (Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands)
Drug response is a complex trait with significant interindividual variability. As a result, many patients suffer from poor drug efficacy and adverse side effects. Genetic variation may account for at least part of the interindividual variability in drug response. Therefore, application of pharmacogenetics may improve both drug safety and efficacy.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.